MYLAN ApS: Financial statements 2023
CVR: 28107013
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
MYLAN ApS (CVR 28107013) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 2,443 and a net result of DKK 1,952 compared with DKK 50 the year before. That is an increase of 8.5% compared with the year before. Equity in the 2023 report amounted to DKK 195,841. The solvency ratio was 76.1%.
- Gross Profit
- DKK 2,443
- Profit/Loss
- DKK 1,952
- Equity
- DKK 195,841
- Total Assets
- DKK 257,301
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 2 t. | 2 t. | 196 t. | - |
| 2022 | - | 2 t. | 50 | 194 t. | 0 |
| 2021 | - | 5 t. | 2 t. | 194 t. | 0 |
| 2020 | - | 5 t. | 2 t. | 192 t. | 0 |
| 2019 | - | 5 t. | 2 t. | 190 t. | 0 |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
MYLAN ApS has published its annual report for 2022. Gross profit came to DKK 2,252, and the net result was DKK 50.
As of April 24, 2023, Bente Brumoen has joined the board of directors of MYLAN ApS.
As of April 24, 2023, Arun Narayan has joined the board of directors of MYLAN ApS.
As of April 24, 2023, Kurt Glud has left the board of directors of MYLAN ApS.
As of April 24, 2023, Luis Rodolfo Birbuet has left the board of directors of MYLAN ApS.
About MYLAN ApS
MYLAN ApS was a Danish company of the type Anpartsselskab based in Ballerup, founded in 2004. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named MERCK NM ApS and NM PHARMA ApS. In 2024, the company reported a gross profit of DKK 3,631 and a net result of DKK 3,137 compared with DKK 1,952 the year before. Equity in the 2024 report amounted to DKK 198,978.